Rapid improvement of Mycobacterium kansasii pneumonia after rifabutin, isoniazid, and ethambutol: A case report

Kaohsiung J Med Sci. 2022 Nov;38(11):1137-1138. doi: 10.1002/kjm2.12608. Epub 2022 Oct 18.

Authors

Hung-I Kuo¹, Shao-Tsung Huang², Ying-Hsun Wu¹

Affiliations

¹ Division of Internal Medicine, Chest Hospital, Ministry of Health and Welfare, Tainan City, Taiwan.
² Division of Infectious Disease, Chest Hospital, Ministry of Health and Welfare, Tainan City, Taiwan.

PMID: 36254860
DOI: 10.1002/kjm2.12608

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antitubercular Agents / therapeutic use
Drug Therapy, Combination
Ethambutol / therapeutic use
Humans
Isoniazid / therapeutic use
Mycobacterium Infections, Nontuberculous* / diagnosis
Mycobacterium Infections, Nontuberculous* / drug therapy
Mycobacterium Infections, Nontuberculous* / microbiology
Mycobacterium kansasii*
Pneumonia*
Rifabutin / therapeutic use

Substances

Ethambutol
Isoniazid
Rifabutin
Antitubercular Agents